Rate My Professor Christopher Grupen

Christopher Grupen's academic interests lie in reproductive biology, embryology, assisted reproductive technologies, ovary function, cryopreservation, embryo development, semen analysis, protein expression, and reproductive medicine. His scholarly output includes 132 publications, garnering 3,401 citations. Prominent works encompass 'Effect of Pre-IVM Duration with cAMP Modulators on the Production of Cloned Equine Embryos and Foals' (2025), 'Nicotinic acid treatment improves the developmental potential of equine oocytes for cloned embryo production' (2026), 'Vitrification of porcine immature oocytes and pronuclear parthenotes delays development at the time of embryonic genome activation: A time-lapse study' (2025), 'A Review of the Monitoring Techniques Used to Detect Oestrus in Sows' (2025), 'Mapping the lipidomic secretome of the early equine embryo' (2024), 'Investigations into the role of platelet-activating factor (PAF) in the peri-conception period of the mare' (2024), 'Quadrupling efficiency in production of genetically modified pigs through CRISPR/Cas9 electroporation of zygotes' (PNAS, 2017), and 'Somatic cell nuclear transfer in horses: effect of oocyte morphology, embryo reconstruction method and donor cell type' (Reproduction, 2005). In recognition of his contributions, he was awarded the Brian Setchell Award by the Society for Reproductive Biology in 2017 (May round). Grupen's research has significantly influenced advancements in cloning, genetic modification, cryopreservation, and embryo production within veterinary science.